$CNS Pharmaceuticals(CNSP)$ 8-K Current report, items 7.01 and 9.01 Accession Number: 0001683168-20-000095 Act: 34 Size: 5 MB 网页链接
$CNS Pharmaceuticals(CNSP)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001683168-19-004044 Act: 34 Size: 2 MB 网页链接
$CNS Pharmaceuticals(CNSP)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001683168-19-003791 Act: 34 Size: 35 KB 网页链接
$CNS Pharmaceuticals(CNSP)$ 8-K Current report, items 5.02, 8.01, and 9.01 Accession Number: 0001683168-19-003575 Act: 34 Size: 36 KB 网页链接
$CNS Pharmaceuticals(CNSP)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0001683168-19-003570 Size: 7 KB 网页链接
$CNS Pharmaceuticals(CNSP)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001683168-19-003571 Size: 5 KB 网页链接
$CNS Pharmaceuticals(CNSP)$ 424B4 - Prospectus [Rule 424(b)(4)] Filed: 2019-11-08 AccNo: 0001683168-19-003503 Size: 1 MB 网页链接
$CNS Pharmaceuticals(CNSP)$ EFFECT - Notice of Effectiveness Filed: 2019-11-07 AccNo: 9999999995-19-002514 Size: 1 KB 网页链接
$CNS Pharmaceuticals(CNSP)$ 8-A12B - Registration of securities [Section 12(b)] Filed: 2019-11-05 AccNo: 0001683168-19-003435 Size: 16 KB 网页链接
$CNS Pharmaceuticals(CNSP)$ CERT - Filed: 2019-11-06 AccNo: 0001354457-19-000572 Size: 86 KB 网页链接